We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Update on Teleflex Recall for Central Venous Catheter Kits
FDA Issues Update on Teleflex Recall for Central Venous Catheter Kits
The FDA has deemed the Oct. 27 recall by Teleflex and subsidiary Arrow International of two central venous catheter kits as Class 1 because of the risk of serious injury or death.